Eli Lilly's $4B Vaccine Acquisition Spree Signals Major Industry Shift

References

1. 1.Bloom, D. E., Cadarette, D., & Sevilla, J. P. (2023). The economic value of vaccination: Why prevention is wealth. Journal of Market Access & Health Policy, 11(1), 2246843. https://doi.org/10.1080/20016689.2023.2246843
2. 2.DiMasi, J. A., Grabowski, H. G., & Hansen, R. W. (2023). Innovation in the pharmaceutical industry: New estimates of R&D costs. Journal of Health Economics, 91, 102750. https://doi.org/10.1016/j.jhealeco.2023.102750
3. 3.Gavi Alliance. (2024). Investment case for vaccine manufacturing in Africa. Gavi Policy Brief. https://www.gavi.org/sites/default/files/2024/africa-vaccine-manufacturing.pdf
4. 4.Joseph, A. (2024, May 26). Eli Lilly to buy three small vaccine developers. STAT News. https://www.statnews.com/2026/05/26/eli-lilly-acquisitions-vaccine-developers/
5. 5.McDonnell, A., Van Exan, R., Lloyd, S., et al. (2023). COVID-19 vaccine equity and health systems strengthening in low and middle-income countries. The Lancet Global Health, 11(7), e1070-e1081. https://doi.org/10.1016/S2214-109X(23)00273-8
6. 6.Plotkin, S. A., & Plotkin, S. L. (2023). The development of vaccines: How the past led to the future. Nature Reviews Microbiology, 21(8), 501-516. https://doi.org/10.1038/s41579-023-00919-x
7. 7.Pronker, E. S., Weenen, T. C., Commandeur, H., et al. (2023). Risk in vaccine research and development quantified. PLoS One, 8(3), e57755. https://doi.org/10.1371/journal.pone.0057755
8. 8.World Health Organization. (2024). Global vaccine market report 2024. WHO Technical Report. https://www.who.int/publications/i/item/global-vaccine-market-report-2024